HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.

AbstractBACKGROUND AND OBJECTIVES:
Hepatitis C virus (HCV) chronic hepatitis predisposes to iron overload, which negatively influences the prognosis of this infection. Since the underlying mechanisms of this iron overload are undefined, we analyzed the prevalence of altered iron parameters, and the relative contribution of viral, metabolic, and genetic factors in Italian patients.
DESIGN AND METHODS:
We studied the metabolic and biochemical characteristics of 143 previously untreated, biopsied patients with HCV who were not alcohol abusers. Hepatic iron was determined according to Deugnier, HFE genotype by restriction analysis, hepcidin, hemojuvelin, ferroportin-1, and transferrin receptor-2 mutations by denaturing high performance liquid chromatography and sequencing.
RESULTS:
Increased transferrin saturation was observed in 20%, hyperferritinemia in 22%, and histological iron deposition in 32% of patients. Ferritin was independently correlated with iron stores and host metabolic parameters, whereas hepatic iron deposition was correlated with ferritin and histological severity of hepatitis. Sinusoidal iron deposition was associated with metabolic alterations, including body mass index, insulin resistance, and LDL cholesterol. Conversely, the prevalence of HFE mutations and serum ferritin values increased with the severity of steatosis. The prevalence of HFE and beta-globin mutations was not different from that of controls (31% and 2%, respectively). No tranferrin receptor-2, hemojuvelin, or ferroportin-1 mutations were detected, but two patients carried the -72C>T hepcidin promoter mutation. The C282Y HFE mutation, hepcidin and beta-globin mutations influenced iron stores. Both carriers of the -72C>T Hepcidin mutation had beta-thalassemia trait, moderate iron overload, and liver cirrhosis.
INTERPRETATION AND CONCLUSIONS:
Iron genes influence iron overload and steatosis development, but the major burden is related to HCV itself and host metabolic factors.
AuthorsLuca Valenti, Edoardo A Pulixi, Paolo Arosio, Laura Cremonesi, Giorgio Biasiotto, Paola Dongiovanni, Marco Maggioni, Silvia Fargion, Anna Ludovica Fracanzani
JournalHaematologica (Haematologica) Vol. 92 Issue 8 Pg. 1037-42 (Aug 2007) ISSN: 1592-8721 [Electronic] Italy
PMID17640859 (Publication Type: Journal Article)
Chemical References
  • Antimicrobial Cationic Peptides
  • Cation Transport Proteins
  • Cholesterol, LDL
  • GPI-Linked Proteins
  • HAMP protein, human
  • HFE protein, human
  • HJV protein, human
  • Hemochromatosis Protein
  • Hepcidins
  • Histocompatibility Antigens Class I
  • Membrane Proteins
  • Receptors, Transferrin
  • TFR2 protein, human
  • Transferrin
  • metal transporting protein 1
  • Ferritins
  • Iron
Topics
  • Adult
  • Antimicrobial Cationic Peptides (genetics)
  • Cation Transport Proteins (genetics)
  • Cholesterol, LDL (blood)
  • Fatty Liver (etiology)
  • Ferritins (blood)
  • GPI-Linked Proteins
  • Genotype
  • Hemochromatosis Protein
  • Hepacivirus (pathogenicity)
  • Hepatitis C, Chronic (complications, genetics, metabolism, pathology)
  • Hepcidins
  • Histocompatibility Antigens Class I (genetics)
  • Humans
  • Iron (analysis, metabolism)
  • Iron Overload (etiology, genetics, metabolism, pathology, virology)
  • Liver (chemistry, metabolism, pathology)
  • Liver Cirrhosis (etiology)
  • Male
  • Membrane Proteins (genetics)
  • Middle Aged
  • Mutation
  • Promoter Regions, Genetic (genetics)
  • Receptors, Transferrin (genetics)
  • Transferrin (analysis)
  • beta-Thalassemia (complications, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: